Guardian Pharmacy Services, Inc. Stock: price and insider trades · United States

This page follows insider dealings at Guardian Pharmacy Services, Inc. as filed with SEC (Form 4). Over the twelve months to 18 October 2026, 38 filings were filed, from 17 insiders.

Open-market activity splits into 1 purchase totalling €86k and 6 sales totalling €150.8M; 1 insider sit on the buying side and 5 insiders on the selling side. On balance, insiders were net sellers of €150.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €91.5M, sold by Bindley William e and made public on 24 March 2026. The buyers include 1 senior executive.

The clock since the last published purchase (5 December 2025) now reads 317 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

For context, the typical company on the same exchange (median of 5,808 companies) published 19 filings over the same period, against 38 filings here. Looking back to 2024, when coverage begins, insiders filed 6 purchases and 18 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 1.45 bn USD and net income at 49.2 m USD.

Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.